Viewing Study NCT00006466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:26 PM
Ignite Modification Date: 2026-03-02 @ 10:05 PM
Study NCT ID: NCT00006466
Status: UNKNOWN
Last Update Posted: 2013-12-18
First Post: 2000-11-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Beta Alethine in Treating Patients With Myeloma
Sponsor: LifeTime Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma and Plasma Cell Neoplasm View
None Precancerous Condition View
Keywords:

Keywords

Keyword Brief Keyword Text View
None monoclonal gammopathy of undetermined significance View
None isolated plasmacytoma of bone View
None extramedullary plasmacytoma View
None refractory multiple myeloma View
None stage I multiple myeloma View
None stage II multiple myeloma View
None stage III multiple myeloma View